118 related articles for article (PubMed ID: 28466781)
1. Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.
Xu G; Lou N; Xu Y; Shi H; Ruan H; Xiao W; Liu L; Xiao H; Qiu B; Bao L; Yuan C; Chen K; Yang H; Zhang X
Tumour Biol; 2017 May; 39(5):1010428317699110. PubMed ID: 28466781
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
3. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
[TBL] [Abstract][Full Text] [Related]
5. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
6. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
7. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.
Yuan B; Wu C; Wang X; Wang D; Liu H; Guo L; Li XA; Han J; Feng H
Tumour Biol; 2016 Mar; 37(3):3581-8. PubMed ID: 26456958
[TBL] [Abstract][Full Text] [Related]
8. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
Wu K; Xu L; Zhang L; Lin Z; Hou J
Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
[TBL] [Abstract][Full Text] [Related]
9. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
[TBL] [Abstract][Full Text] [Related]
10. PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.
Wang K; Ruan H; Song Z; Cao Q; Bao L; Liu D; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Yang H; Chen K; Zhang X
Urol Oncol; 2018 Jul; 36(7):343.e9-343.e19. PubMed ID: 29773494
[TBL] [Abstract][Full Text] [Related]
11. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
13. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
16. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Stein J; Tenbrock J; Kristiansen G; Müller SC; Ellinger J
Int J Urol; 2019 Sep; 26(9):910-916. PubMed ID: 31280487
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
Wang Y; Gao W; Xu J; Zhu Y; Liu L
Tumour Biol; 2017 May; 39(5):1010428317698377. PubMed ID: 28459210
[TBL] [Abstract][Full Text] [Related]
18. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of a gene signature in clear cell renal cell carcinoma.
Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
[TBL] [Abstract][Full Text] [Related]
20. Expression and significance of Cystatin-C in clear cell renal cell carcinoma.
Guo K; Chen Q; He X; Yao K; Li Z; Liu Z; Chen J; Liu Z; Guo C; Lu J; Wu C; Li W; Wang Q; Chen P; Lu W; Wang Y; Han H; Cao Y; Guo S
Biomed Pharmacother; 2018 Nov; 107():1237-1245. PubMed ID: 30257338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]